The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...

Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...

People with more severe plaque psoriasis may need more treatments that target the body ... or common cold symptoms. The best way to prevent infection is to reduce your exposure to germs by ...

The approval was supported by data from 2 randomized, double-blind, vehicle-controlled trials that included 736 patients aged 12 years and older with mild to severe plaque psoriasis of the scalp and ...

"More than six million people in the U.S. live with plaque psoriasis. So I'm definitely not alone in this journey, and I just want to help people as best I can." Effective treatment options for ...

Plaque psoriasis, a chronic autoimmune disorder that causes thick, scaly, itchy patches—the eponymous plaques—to form on the skin, affects more than 7.5 million adults in the United States.

Guselkumab treatment was associated with improvements in 3 biomarkers associated with systemic inflammation among patients with plaque psoriasis.

Scalp psoriasis is typically caused by plaque psoriasis ... psoriasis. Treatment can differ for each person. It's important to consult a dermatologist to figure out what works best for you.

Whether treatment of plaque psoriasis decreased mortality ... The authors called cell therapy "the best chance to cure psoriasis." In particular, they cited the potential for mesenchymal stem ...

Erythrodermic psoriasis is a very rare type of psoriasis that affects up to just over 2% of people with psoriasis, usually plaque psoriasis ... to find the treatment that works best for you.

“In addition to the skin, psoriasis can also affect joints resulting in psoriatic arthritis.” Stull said that a number of prescription treatments ... Before your next plaque surfaces and ...